{"transactions":[{"id":1371061,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-08T17:00:06.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":0.358,"exercise_date":"2025-10-11","expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0000950170-24-124217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024124217/ownership.xml","form_type":"4"}},{"id":1406449,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-16T16:30:07.000Z","date":"2024-09-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.4672,"value":2336.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.458 to $0.480, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-24-106857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024106857/ownership.xml","form_type":"4"}},{"id":1426364,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-21T17:57:26.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":3600,"price":0.894,"value":3218.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.889 to $0.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-099586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024099586/ownership.xml","form_type":"4"}},{"id":1478639,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T08:21:24.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares beneficially owned by the Reporting Person include 54,455 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of June 12, 2024."}],"balance_after":54445,"source":{"system":"sec-edgar","filing":"0000950170-24-073349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024073349/ownership.xml","form_type":"4"}},{"id":1478638,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T08:21:24.000Z","date":"2024-06-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.2046,"value":4409.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.1835 to $2.2257, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2"}],"balance_after":6400,"source":{"system":"sec-edgar","filing":"0000950170-24-073349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017024073349/ownership.xml","form_type":"4"}},{"id":1712209,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares beneficially owned by the Reporting Person include 44,845 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023."}],"balance_after":44845,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1712208,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":2400,"price":3.471,"value":8330.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.46 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2"}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1712207,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:53:44.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.5,"value":7000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-23-070174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000095017023070174/ownership.xml","form_type":"4"}},{"id":1827670,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants","published_at":"2023-07-18T20:36:11.000Z","date":"2023-07-14","kind":"other","planned":false,"acquired":true,"shares":69,"ownership":{"direct":false,"nature":"Harbor Light Direct Investment, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These warrants are currently exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Upton is General Partner at Harbor Light Capital Partners, which is affiliated with the entities listed above.  By virtue of this relationship, Mr. Upton may be deemed to share beneficial ownership of the securities held of record by the entities listed above.  Mr. Upton disclaims any such beneficial ownership except to the extent of his pecuniary interest."}],"balance_after":69,"derivative":{"exercise_price":6.7107,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0001062993-23-015056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000106299323015056/form4.xml","form_type":"4"}},{"id":1827669,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants","published_at":"2023-07-18T20:36:11.000Z","date":"2023-07-14","kind":"other","planned":false,"acquired":true,"shares":895,"ownership":{"direct":false,"nature":"Carmell Series of Harbor Light Direct Investment, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These warrants are currently exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Upton is General Partner at Harbor Light Capital Partners, which is affiliated with the entities listed above.  By virtue of this relationship, Mr. Upton may be deemed to share beneficial ownership of the securities held of record by the entities listed above.  Mr. Upton disclaims any such beneficial ownership except to the extent of his pecuniary interest."}],"balance_after":895,"derivative":{"exercise_price":6.7107,"expiration_date":"2024-09-30","underlying":"Common Stock","underlying_shares":895},"source":{"system":"sec-edgar","filing":"0001062993-23-015056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000106299323015056/form4.xml","form_type":"4"}},{"id":1827668,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":86214,"kind":"person","name":"Upton Richard A","position":1,"cik":"0001375726","reported_name":"Upton Richard A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-18T20:36:11.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":76878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 76,878 shares of common stock of Legacy Carmell (as defined below) granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":76878,"derivative":{"exercise_price":2.11,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0001062993-23-015056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375726/000106299323015056/form4.xml","form_type":"4"}}]}